Evidence map›Paper›PMID 27270319›Full record

ArticleOncotarget2016

E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.

Katie Palen, James Weber, Michael B Dwinell, Bryon D Johnson, Ramani Ramchandran, Jill A Gershan

Abstract readComparative Study
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Epithelial-Mesenchymal Transition in Acute Leukemias.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. The Journey of Cancer Cells to the Brain: Challenges and Opportunities.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. [Effect of the focal adhesion kinase inhibitor TAE226 on the epithelial-mesenchymal transition in human oral squamous cell carcinoma cell line].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2020
    Article
  12. [Effect of down-regulation of sex determining region Y-box 9 on epithelial mesenchymal transition and cloning of oral squamous carcinoma cells].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katie PalenDepartment of Pediatrics at The Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
James WeberDepartment of Pediatrics at The Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Michael B DwinellDepartment of Microbiology and Molecular Genetics at The Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Bryon D JohnsonDepartment of Pediatrics at The Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Ramani RamchandranDepartment of Pediatrics at The Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Jill A GershanDepartment of Pediatrics at The Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.

Funding

REGULATING CEREBRAL MICROCIRCULATION BY ASTROCYTESR01HL033833 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HARDER, DAVID RAE · 1985 to 2017
$5.8M
Targeting DUSP-5 to Treat Vascular AnomaliesR01HL112639 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI RAMCHANDRAN, RAMANI · 2012 to 2016
$2.6M
Delta like-4 long non-coding RNA function in angiogenesis and vascular anomaliesR01HL123338 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI RAMCHANDRAN, RAMANI · 2015 to 2018
$1.8M
CELLULAR CONTROL MECHANISMS OF CEREBROVASCULAR TONER37HL033833 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HARDER, DAVID R · 1990 to 1999
–
NHLBI NIH HHS HHSN268201400009CNHLBI NIH HHS R01 HL033833NHLBI NIH HHS R01 HL112639NHLBI NIH HHS R01 HL123338NHLBI NIH HHS R37 HL033833
6 · The paper itself

Abstract

Substantial experimental evidence has shown that dedifferentiation from an epithelial state to a mesenchymal-like state (EMT) drives tumor cell metastasis. This transition facilitates tumor cells to acquire motility and invasive features. Intriguingly, tumor cells at the metastatic site are primarily epithelial, and it is believed that they differentiate back to an epithelial state by a process called mesenchymal to epithelial transition (MET). However, there is little in vivo evidence to support the MET process. To investigate EMT and MET in vivo, we generated two epithelial (E) and two mesenchymal (M) primary clonal cell lines from a spontaneous mouse mammary tumor (Tg MMTV/neu). These cells were labeled with reporters (GFP and luciferase), and tracked in vivo during primary tumor growth and subsequent secondary metastasis. Once E cells were implanted into the mammary fat pad, E-cadherin expression progressively decreased and continued to decrease as the primary tumor enlarged over time. A greater percentage of E tumor cells expressed E-cadherin at the secondary metastatic site as compared to the corresponding primary tumor site. Collectively, these data provide direct in vivo evidence that epithelial tumor cells have metastatic potential, undergo EMT at the primary tumor site, and MET at the metastatic site.

Indexed as

Epithelial-Mesenchymal TransitionAnimalsBreastCadherinsCell Line, TumorCell MovementClone CellsEpithelial CellsFemaleFlow CytometryGene Expression Regulation, NeoplasticLiver Neoplasms, ExperimentalLung NeoplasmsMammary Neoplasms, ExperimentalMiceMicroarray AnalysisCadherinsCdh1 protein, mousebreast cancerE-cadherinEMTMETmetastasis

Identifiers

PMID27270319
PMCPMC5190029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.